Form 4 for CVS CVS Health
Accepted 2023-09-01 00:00:00 ET · period of report 2023-08-31 · accession 0001127602-23-023580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-01 | 2023-08-31 | CVS | Mandadi Tilak | EVP, CTO | F - Tax | $65.17 | -13.1K | 20.2K | -39% | -$850.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-31 | F | D | 13,053 | $65.17 | 20,229 | D | — | — | (F1) Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. |